Skip to main content

Table 1 Baseline characteristics of patients

From: Lubiprostone, a novel laxative, might improve hyperphosphatemia without water dilution

Number of enrolled patients (men/women) 28 (14/14)
Age, years 69.4 ± 14.2
Duration of dialysis, years 7.7 ± 9.1
Underlying disease of renal failure Diabetic nephropathy, 11 patients
Chronic glomerulonephritis, 3 patients
Nephrosclerosis, 5 patients
Autosomal dominant polycystic kidney disease, 1 patient
Primary hyperparathyroidism, 1 patient
Unknown, 7 patients
Concomitant laxative 17 patients
Stimulant laxative, 17 patients
Sugar laxative, 1 patient
Phosphate binder 18 patients
Calcium carbonate, 8 patients
Lanthanum carbonate, 12 patients
Bixalomer, 2 patients
Ferric citrate hydrate, 1 patient
Cinacalcet, 4 patients